Some drugs had too little of the active ingredient while others had fatal concentrations. In others, dosage inconsistencies were found within the same blister pack!
What could this mean for the future of pharmacy and medicine in India?
Won’t the world question the integrity of our research and global contributions?
With institutions like the NCI falling apart, could we be relied on if we made waves in these medical circles?
For every formulation manufacturer first validate the procedure then they start processing. Without FDA approval drug cannot be launched to the market. Any change observed or complaint can recall whole batch and that is a big loss for the company.
Both PCI and FDA should prioritize this issue and take prompt action. If left unaddressed, it could lead to a growing negative impact on healthcare professionals and compromise the integrity of the system.
Recent drug quality issues in India are concerning, with reports of quality of the medication. This situation raises questions about India’s reputation as the “Pharmacy of the World”. Improved drug regulation and quality control are needed to maintain trust and protect lives globally.
The drugs that are released after post marketing should be checked upon involving their quality and processes lik analysis, assessment and testings should be done very carefully and ethically and then should be released.
A new report says that some cancer medicines made in India are not safe. About 1 out of every 5 samples failed the quality test. Some had less medicine, so they may not work well, and some had too much, which can harm patients. These drugs were sent to many countries. This happened because of poor checking and companies trying to save money. It is dangerous for patients who need proper treatment.
The reason might be the weak regulation and cost cutting by the manufacturer.
This raises serious concerns about India’s drug safety and global trust. If dosage flaws continue, the world may question our pharma credibility and research integrity. With global institutions like NCI weakening, India has a chance to lead but only if we ensure strict quality, transparency, and ethics in medicine.
This is concerning. How might someone without specialised knowledge understand this?
All we can say is that this situation has severely undermined morality.
Drug should undergo all quality standards,fda ,cdsco procedures.
All the clinical study should done through ly.core research, authenticity should be maintained.
Low cost means low quality drug should avoided.
India is often called the “pharmacy of the world”, supplying generic drugs to over 200 countries. But if these lapses continue like this, global confidence in Indian pharmaceuticals could decline. Having such kind of inconsistencies is both harmful for the people as well as the country’s overall global recognition.
Chemo drugs are life-saving, and if their quality is poor, it puts lives at serious risk. If this continues, people will lose trust in Indian pharma, and even our global image might get affected. It is more important for us to stay strong and maintain quality. Pharmacy should never be about money over lives.
Drugs and dosage inconsistencies are a matter of great concern especially in cases of serious life threatening diseases. It would obviously impact the patients helath and put their life at risk which is a concern for morality. As it is happening in a developing country like India, it would surely question our country’s integrity and credibility globally. Hence, strict regulatory restrictions and approval policies should be implemented and appropriate actions should be taken in case of any non-compliance and non-adherence.
Before manufacturing these drugs we should approved them by the approval association and also write the best standard operating procedures and also think about the concern before taking any wrong step.
The world will judge not just by what went wrong but by how India responds.
Yes ,the world questions the integrity based on the drug failure;But with the experience and knowledge research team along with the quality check ups we could increase the positive outcome of the drug along with better patient outcome.Already India’s drug Technical advisory board is compelling for automatic license suspension if drug fails the test.There should be an rise in the quality regarding better labs,digital traceability and third party certifications.Yes,we could rely on many top institutes for better research outcome.
India has never been funding much for research and due to this for marketing of many drugs there have been false research tests shown and no one knows how badly the drug could effect you
Yes, nowadays such problems are arising . This problem is due to lack of the Quality management team.Every medication has its Standard procedure and amount of the active pharmaceutical ingredient (API)used.Also how should be the packaging done with all rules and regulations. Such situation are an eye-opener for pharmaceutical industries to keep check on their formulation and packaging of the drugs.
It is concerning that these kinds of mistakes are being made in the medicines that treat the most dangerous and life threatning conditions. Manufacturers should conduct through quality check for a drug before it is released and proper equipment should be employed to make sure that each tablet and vial are getting the same amount of drug.
It hits so hard hearing this side of the profession we belong to. The harsh reality. These things happen in such a long chain. Very concerning.